Trexquant Investment LP Aurinia Pharmaceuticals Inc. Transaction History

Trexquant Investment LP

$7.59 Billion
Q3 2024

A detailed history of Trexquant Investment LP transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 583,022 shares of AUPH stock, worth $5.57 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

583,022

Previous 243,502 139.43%

Holding current value

$5.57 Million

Previous $1.39 Million 207.41%

% of portfolio

0.06%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$5.32 - $7.33 $1.81 Million - $2.49 Million	339,520 Added 139.43%	583,022 $4.27 Million
Q2 2024 Aug 13, 2024	SELL	$4.81 - $5.78 $243,862 - $293,040	-50,699 Reduced 17.23%	243,502 $1.39 Million
Q1 2024 May 14, 2024	BUY	$4.93 - $9.31 $1.45 Million - $2.74 Million	294,201 New	294,201 $1.47 Million
Q3 2023 Nov 13, 2023	SELL	$7.77 - $12.27 $2.06 Million - $3.26 Million	-265,615 Reduced 83.0%	54,403 $422,000
Q2 2023 Aug 11, 2023	BUY	$8.96 - $11.69 $1.21 Million - $1.57 Million	134,576 Added 72.57%	320,018 $3.1 Million
Q1 2023 May 15, 2023	BUY	$5.94 - $11.27 $520,450 - $987,454	87,618 Added 89.57%	185,442 $2.03 Million
Q4 2022 Feb 13, 2023	SELL	$4.11 - $8.14 $20,993 - $41,579	-5,108 Reduced 4.96%	97,824 $422,000
Q3 2022 Nov 14, 2022	BUY	$6.66 - $12.39 $393,346 - $731,765	59,061 Added 134.62%	102,932 $774,000
Q2 2022 Aug 11, 2022	BUY	$8.95 - $12.8 $392,645 - $561,548	43,871 New	43,871 $441,000
Q1 2022 May 13, 2022	SELL	$10.05 - $22.48 $213,160 - $476,800	-21,210 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$17.78 - $33.08 $377,113 - $701,626	21,210 New	21,210 $485,000
Q3 2021 Nov 12, 2021	SELL	$10.93 - $23.55 $283,742 - $611,358	-25,960 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$10.0 - $14.52 $96,880 - $140,669	-9,688 Reduced 27.18%	25,960 $336,000
Q1 2021 May 13, 2021	BUY	$12.3 - $18.73 $438,470 - $667,687	35,648 New	35,648 $463,000
Q4 2020 Feb 11, 2021	SELL	$12.94 - $16.05 $246,908 - $306,250	-19,081 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$13.19 - $16.66 $251,678 - $317,889	19,081 New	19,081 $281,000
Q1 2020 May 08, 2020	SELL	$11.34 - $21.46 $751,887 - $1.42 Million	-66,304 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$3.88 - $21.42 $257,259 - $1.42 Million	66,304 New	66,304 $1.34 Million

Others Institutions Holding AUPH

# of Institutions

208

Shares Held

58.6M

Call Options Held

1.14M

Put Options Held

1.51M

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.36B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account

Trexquant Investment LP Aurinia Pharmaceuticals Inc. Transaction History